Newsfeeds - Spark Newswire

3 minute read

Onconova Therapeutics Announces Updated Data From Investigator-sponsored Phase 1/2a Trial Evaluating Rigosertib In Combination With Nivolumab In Advanced KRAS-Mutated Non-Small Cell Lung Cancer At The ESMO Congress 2022

Today, 1:37 PM

Data show an early signal of efficacy in an extensively pre-treated population with 1 complete response and 2 partial responses achieved in 14 evaluable patients Responses achieved in patients with 3

ONTX

2 minute read

Earnings

Looking Into Onconova Therapeutics’s Return On Capital Employed

By Benzinga Insights

Today, 1:37 PM

According to data from Benzinga Pro, during Q2, Onconova Therapeutics's (NASDAQ:ONTX) reported sales totaled $57 thousand. Despite a 2.38% increase in earnings, the company posted a loss of $4.02 million.

ONTX

17 minute read

Earnings Scheduled For August 11, 2022

By Benzinga Insights

Today, 1:37 PM

Companies Reporting Before The Bell • Magic Software (NASDAQ:MGIC) is projected to report quarterly earnings at $0.27 per share on revenue of $131.70 million.

AACG

5 minute read

74 Biggest Movers From Yesterday

By Lisa Levin

Today, 1:37 PM

Gainers

ACOR

4 minute read

53 Stocks Moving In Thursday’s Mid-Day Session

By Lisa Levin

Today, 1:37 PM

Gainers

ACOR

1 minute read

Earnings

Recap: Onconova Therapeutics Q1 Earnings

By Benzinga Insights

Today, 1:37 PM

Onconova Therapeutics (NASDAQ:ONTX) reported its Q1 earnings results on Wednesday, May 11, 2022 at 04:00 PM. Here's what investors need to know about the announcement.

ONTX

12 minute read

Earnings Scheduled For May 11, 2022

By Benzinga Insights

Today, 1:37 PM

Companies Reporting Before The Bell • Great Elm Capital (NASDAQ:GECC) is expected to report earnings for its first quarter.

ACOR

1 minute read

Earnings

Onconova Therapeutics Earnings Preview

By Benzinga Insights

Today, 1:37 PM

Onconova Therapeutics (NASDAQ:ONTX) is set to give its latest quarterly earnings report on Wednesday, 2022-05-11. Here's what investors need to know before the announcement. Analysts estimate that Onconova Therapeutics will report an earnings per share (EPS) of $-0.19.

ONTX

1 minute read

Earnings

Recap: Onconova Therapeutics Q4 Earnings

By Benzinga Insights

Today, 1:37 PM

Onconova Therapeutics (NASDAQ:ONTX) reported its Q4 earnings results on Thursday, March 17, 2022 at 04:00 PM. Here's what investors need to know about the announcement.

ONTX